BiotechTube
Home/NextCure/James J. Peyer
JJ

James J. Peyer

Board Member

NextCure

Therapeutic Areas

OncologyImmunology

NextCure Pipeline

DrugIndicationPhase
NC318Non-small cell lung cancer (NSCLC), ovarian cancer, other solid tumorsPhase 1/2
NC410Solid tumors (e.g., colorectal, ovarian, pancreatic)Phase 1/2
NC525Acute Myeloid Leukemia (AML)Preclinical

Leadership Team at NextCure

MR
Michael Richman
Former President and Chief Executive Officer
SL
Solomon Langermann
Senior Vice President, Research & Development
KC
Kevin C. Deenihan
Chief Financial Officer
TM
Timothy Mayer
Chief Operating Officer
LC
Lieping Chen
Co-Founder and Scientific Advisor
ER
Ellen R. Lubman
Chief Business Officer
View full NextCure profile